Changes in Lipid Profile after Biliopancreatic Diversion

Obesity Surgery

Volumn 13, Issue 5, 2003, Pages 756-760

  De Dios García Díaz, Juan ^a,b   Lozano, Oscar ^b   Ramos, Juan Carlos ^a   Gaspar, Ma Jesús ^b   Keller, Jerry ^b   Duce, Antonio Martín ^b  

^a Service of Pathology   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

Bariatric surgery; Biliopancreatic diversion; Cardiovascular risk; Lipoproteins; Malabsorptive surgery; Morbid obesity

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; ATHEROSCLEROSIS; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; ILEOCECAL VALVE; JEJUNOILEOSTOMY; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TOTAL STOMACH RESECTION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; BILIOPANCREATIC DIVERSION; FEMALE; GASTRECTOMY; HUMANS; LIPIDS; MALE; MIDDLE AGED; OBESITY, MORBID; PROSPECTIVE STUDIES; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 0242298708     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089203322509345     Document Type: Article

References (29)

1. Flegal KM, Carroll MD, Ogden CL et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288: 1723-7.
2. Freedman DS, Khan LK, Serdula MK et al. Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 2002; 288: 1758-61.
3. Mun EC, Blackburn GL, Matthews JB. Current status of medical and surgical therapy for obesity. Gastroenterology 2001; 120: 669-81.
4. National Institutes of Health Consensus Development Conference Draft Statement. Gastrointestinal surgery for severe obesity. Obes Surg 1991; 1: 257-66.
5. Deitel M, Shikora SA. The development of the surgical treatment of morbid obesity. J Am Coll Nutr 2002; 21: 365-71.
6. Jousilahti P, Tuomilehto J, Vartiainen E et al. Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland. Circulation 1996; 93: 1372-9.
7. Marceau P, Hould FS, Lebel S et al. Malabsorptive obesity surgery. Surg Clin North Am 2001; 81: 1113-27.
8. Scopinaro N, Adami GF, Marinari GM et al. Biliopancreatic diversion. World J Surg 1998; 22: 936-946.
9. Scopinaro N, Adami GF, Marinari GM et al. Biliopancreatic diversion: two decades of experience. In: Deitel M, Cowan GSM Jr, eds. Update: Surgery for the Morbidly Obese Patient. Toronto, Canada: FD-Communications 2000: 227-58.
10. Sánchez-Cabezudo C, Larrad Jiménez A. Analysis of weight loss with the biliopancreatic diversion of Larrad: absolute failures or relative success. Obes Surg 2002; 12: 249-52.
11. Sheehan MT, Jensen MD. Metabolic complications of obesity. Pathophysiologic considerations. Med Clin North Am 2000; 84: 363-85.
12. Dengel JL, Katzel LI, Goldberg AP. Effect of an American Heart Association diet, with or without weight loss, on lipids in obese middle-aged and older men. Am J Clin Nutr 1995; 62: 715-21.
13. Sjostrom CD, Lissner L, Wedel H et al. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999; 7: 477-84.
14. Busetto L, Pisent C, Rinaldi D et al. Variation in lipid levels in morbidly obese patients operated with the Lap-Band adjustable gastric banding system: Effects of different levels of weight loss. Obes Surg 2000; 10: 569-77.
15. Olsson SA, Petersson BG, Sorbris R et al. Effects of weight reduction after gastroplasty on glucose and lipid metabolism. Am J Clin Nutr 1984; 40: 1273-80.
16. Manzato E, Zambon S, Zambon A et al. Lipoprotein subfraction levels and composition in obese subjects before and after gastroplasty. Int J Obes 1992; 16: 573-8.
17. von Schenck H, Wallentin L, Lennmarken C et al. Lipoprotein metabolism following gastroplasty in obese women. Scand J Clin Lab Invest 1992; 52: 269-74.
18. Wolf AM, Beisiegel U, Kortner B et al. Does gastric restriction surgery reduce the risks of metabolic diseases? Obes Surg 1998; 8: 9-13.
19. Karason K, Wikstrand J, Sjostrom L et al. Weight loss and progression of early atherosclerosis in the carotid artery: a four-year controlled study of obese subjects. Int J Obes 1999; 23: 948-56.
20. Brolin RE, Kenler HA, Wilson AC et al. Serum lipids after gastric bypass surgery for morbid obesity. Int J Obes 1990; 14: 939-50.
21. Gleysteen JJ. Results of surgery: long-term effects on hyperlipidemia. Am J Clin Nutr 1992; 55 (Suppl 2): 591S-593S.
22. Buffington CK, Cowan GSM Jr. Gastric bypass in treatment of diabetes, hypertension and lipid/lipoprotein abnormalities of the morbidly obese. In: Deitel M, Cowan GSM Jr, eds. Update: Surgery for the Morbidly Obese Patient. Toronto, Canada: FD-Communications 2000: 435-50.
23. Sugerman HJ, Kellum JM, DeMaria EJ. Conversion of proximal to distal gastric bypass for failed gastric bypass for superobesity. J Gastrointest Surg 1997; 1: 517-25.
24. Murr MM, Balsiger BM, Kennedy FP et al. Malabsorptive procedures for severe obesity: comparison of pancreaticobiliary bypass and very very long limb Roux-en-Y gastric bypass. J Gastrointest Surg 1999; 3: 607-12.
25. Lagace M, Marceau P, Marceau S et al. Biliopancreatic diversion with a new type of gastrectomy: some previous conclusions revisited. Obes Surg 1995; 5: 411-8.
26. Boman L, Ericson M. Lipoprotein A levels after intestinal bypass operation for morbid obesity. Obes Surg 1997; 7: 125-7.
27. Buchwald H, Varco RL, Boen JR et al. Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year post-trial follow-up report from the POSCH. Arch Intern Med 1998; 158: 1253-61.
28. Cummings DE, Weigle DS, Frayo RS et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346: 1623-30.
29. Geloneze B, Tambascia MA, Pilla VF et al. Ghrelin: a gut-brain hormone: effect of gastric bypass surgery. Obes Surg 2003; 13: 17-22.